|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 2.900 USD | -.--% |
|
-6.75% | -27.50% |
| 09-20 | X4 Pharmaceuticals, Inc.(NasdaqCM:XFOR) added to S&P Global BMI Index | CI |
| 09-08 | X4 Pharmaceuticals Reaches FDA Agreement on Revised Phase 3 Trial for Chronic Neutropenia Treatment | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| XFOR | Delayed | |
CBOE
| XFOR | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 3.4 | 3.62 | 3.58 |
| Spread/Res. | -14.71% | -19.89% | -18.99% |
| Spread/Supp. | +3.57% | +16.47% | +11.03% |
| Support | 2.8 | 2.49 | 2.612 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- XFOR Stock
- Charts X4 Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
